Published July 2019 | Version v1
Journal article

Maintaining radiochemical purity of [177Lu]Lu-DOTA-PSMA-617 for PRRT by reducing radiolysis

  • 1. Nano-Instrumentation, TNO, Delft (Netherlands)
  • 2. AlfaRim Medical Holding BV, Delft (Netherlands)
  • 3. University Medical Center Rotterdam, Rotterdam (Netherlands). Department of Internal Medicine
  • 4. University Medical Center Rotterdam, Rotterdam (Netherlands). Department of Radiology and Nuclear Medicine

Description

[177Lu]Lu-DOTA-PSMA-617 for PRRT is subject to radiolysis and therefore loses receptor affinity. This will be detrimental for treatment efficacy. In this study optimal quencher(s) (combinations) are determined to maintain radiochemical purity with a downscaled model. Downscaled model in terms of activity, but at similar concentrations. DOTA-PSMA-617 was labeled with [177Lu]LuCl3 with different molar- and volume activities. Either methionine, ethanol or both showed superior effects on the stabilizing radiochemical purity of [177Lu]Lu-DOTA-PSMA-617. As a consequence, radiochemical purity of [177Lu]Lu-DOTA-PSMA-617 could be maintained by the addition of methionine and/or ethanol and downscaled model was proven and complementary. (author)

Additional details

Publishing Information

Journal Title
Journal of Radioanalytical and Nuclear Chemistry
Journal Volume
321
Journal Issue
1
Journal Page Range
p. 285-291
ISSN
0236-5731
CODEN
JRNCDM

Optional Information

Notes
21 refs.